IL2 and cancer: For immunotherapy of cancer, γδ T cells can be stimulated by aminobisphosphonates or natural or synthetic phosphoantigens, known to stimulate the Vy9Vδ2 T cells, and an addition of co-stimulators like interleukin 2 (IL-2) [9,10,11].